International Journal of Orthopaedics Sciences

Role of intralesional polidocanol in management of Aneurysmal bone cyst.

2020, Volume 6 Issue 4

Role of intralesional polidocanol in management of Aneurysmal bone cyst.

Author(s): Dr. Wajahat Ahmad Mir, Dr. Javaid Ahmad Ganaie, Dr. Rasiq Rashid, Dr. Imran Khan and Dr. Ab Hai Qureshi
Abstract: Background: Aneurysmal bone cyst is a true benign bone tumor often seen in young children and adolescents. ABCs often present with impending or pathological fracture due its aggressive cortical erosion. Modalities of treatment viz: Curettage with or without graft, Enbloc excision, cryotherapy, argon beam laser, radiotherapy, arterial embolization are often associated high morbidity & high complication rates.
Objectives: The aim of this study was to evaluate the clinical & radiological efficacy of polidocanol in the management of Aneurysmal bone cyst. Material & Methods: After radiological and cytological confirmation of ABC, 18 patients meeting the inclusion criteria were included in this study. The patients were treated with intralesional polidocanol under fluoroscopic guidance.
Results: The mean age of patients was 8.2 years. Mean number of injections required was 3.2, with three patients showing radiological resolution after single injection. Recurrence was seen in 1 patient after showing initial resolution. There were no cases of anaphylaxis or local inflammatory reactions.
Conclusion: Polidocanol is a safe and inexpensive alternative to other modalities of treatment and should always be first line of treatment for the management of the Aneurysmal bone cyst.
Pages: 599-601  |  688 Views  84 Downloads
How to cite this article:
Dr. Wajahat Ahmad Mir, Dr. Javaid Ahmad Ganaie, Dr. Rasiq Rashid, Dr. Imran Khan, Dr. Ab Hai Qureshi. Role of intralesional polidocanol in management of Aneurysmal bone cyst.. Int J Orthop Sci 2020;6(4):599-601. DOI: 10.22271/ortho.2020.v6.i4i.2391
 
International Journal of Orthopaedics Sciences
Call for book chapter